Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 155 for “"Immune effector"”.
-
Immune-Effector Pathways Leading To Peanut-Induced Anaphylaxis
… Moreover, they demonstrate that distinctive immune effector pathways involving activation of mast cells (via IgE and IgG<sub>1</sub>) and macrophages (via IgG<sub>1</sub>) cooperate to elicit a broad range of systemic reactions to peanut. These findings highlight that concomitant and …
-
The innate immune effector cell response against HIV-1
… for a vaccine. Understanding the basis of an immune response that controls infection or provides sterilizing immunity remains a major goal in the search for effective vaccines or immunotherapies. Research into correlates of immunity to HIV-1 have largely focused on CD8<sup>+</sup> T cells or …
-
Optimisation of immune effector function within the tumour microenvironment
… and acceptance of the intrinsic role of the immune system in cancer pathogenesis, pathophysiology and treatment represented such a “blue sky” thought. Moreover, the embracement of immunotherapy, the concept of targeting immune cells rather than the tumour cells themselves, represents a …
-
Contributions of immune effector cells to cancer and sex-biased aging
The immune system, a complex network of cells and molecules, is vital for defending the body against infections, malignancies, and other pathological conditions. Central to this system are immune effector cells, which play crucial roles in recognizing and eliminating pathogens and targeting …
-
Dissecting the phospholipid signaling pathways triggered by Fc receptors in human immune effector cells
… linking up the humoral and cellular arms of the immune system. Upon receptor aggregation, intracellular signaling cascades are triggered via the recruitment and activation of non-receptor tyrosine kinases, leading to the release of potent proinflammatory mediators, including: cytokines, …
-
The dynamics of anti-tumour responses generated by chimeric antigen receptor-modified immune effector cells
… tumours. Understanding the biology of CART cell effector function may explain treatment failure, and lead to more effective cell therapy products. Population-based assays such as flow cytometry give a snapshot of these complex cellular systems, but do not allow one to study the fate of individual …
-
Cellular phenotypes correlated with immune effector cell-associated neurotoxicity syndrome severity in CD19 CAR T cell therapy
… most notably cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS). While CRS is often mitigated through IL-6 pathway blockade, the underlying mechanisms driving ICANS remain incompletely understood.In this thesis, I leverage high-dimensional mass …
-
Establishment of a co-culture system to study the interactions between major immune effector cells and hepatocellular carcinoma
The immune system plays an essential role in protecting humans from cancer, especially the major immune effector cells such as CD8+ T lymphocytes and NK cells. In recent years, immunotherapy has developed greatly, especially with regard to checkpoint blockade and cellular therapies. As the fourth …
-
Corona Virus 229E, NL63 And OC43 Infection Of Human Monocyte-Derived Dendritic Cells: Modulation of Immune Effector Function
… thought to be an effective mechanism for viral-immune evasion. The severe-acute respiratory syndrome coronavirus (SARS-CoV) has been shown to infected human myeloid dendritic cells (MDCs) and directly modulate the cellular cytokine production. The ability of other human coronaviruses to infect …
-
THE LATENT RESERVOIR IN ELITE CONTROLLERS AND FACTORS THAT AFFECT THE SUPPRESSIVE CAPACITIES OF IMMUNE EFFECTOR CELLS IN HIV POSITIVE INDIVIDUALS
… of viral proteins renders them visible to the immune system for targeted elimination and second to achieve this in the presence of antiretroviral therapy (ART) so as to prevent new rounds of infection. Despite the allure of the shock-and-kill strategy, there has been no evidence to date of an …
-
Modelling immune effector cell-associated neurotoxicity syndrome (ICANS): The impact of the CAR-T cell effector response on human iPSC-derived microglia
… neurological toxicities collectively termed immune effector cell–associated neurotoxicity syndrome (ICANS). ICANS presents with encephalopathy, seizures and, in severe cases, cerebral oedema. Although systemic cytokine release, endothelial activation, blood–brain barrier (BBB) disruption and …
-
T cell-dependent lysis of CD19-positive leukemia cells mediated by single-chain triplebodies with dual-targeting
… interaction of antibody derivatives with immune effector cells and multiple tumor-associated antigens is expected to increase cancer cell selectivity, to block cancer cell survival mechanisms and to hamper immune escape. For this purpose a large number of bi- and multispecific molecular …
-
The pleiotropic effect of statins on immune cell function
… and membrane rafts were investigated in immune effector cells. T cells and NK cells were extracted from various groups of patients treated with statins and proliferation and cytotoxicity respectively, measured ex vivo. In a study of patients with cardiovascular disease, a 23% reduction in …
-
Exploring strain variation and bacteriophage predation in the gut microbiome of Ciona robusta
… (e.g. bacteria, viruses) and the host immune system (e.g. innate immune molecules) is necessary for balancing health and disease outcomes within the host. These studies most often utilize vertebrate models; however, research in this field can benefit from diverse model systems that …
-
THE ROLE AND TARGETING OF INTEGRIN BETA 6 IN PANCREATIC DUCTAL ADENOCARCINOMA
… as dual affinity retargeting (DART), which links immune "effector" cells to cancerous "target" cells that express integrin β6. The DART molecule acts by concurrently activating the immune effector cells and facilitating the lysis of the integrin β6 target cells. We showed that this targeting …
-
DEVELOPMENT OF NOVEL IN-VIVO-LAUNCHED MULTIVALENT T CELL ENGAGERS FOR TARGETING INTRATUMORAL HETEROGENEITY IN GLIOBLASTOMA MULTIFORME
… landscape of GBM and engage a broad range of immune effector populations to enhance therapeutic efficacy.To investigate this problem, two novel immunotherapeutic approaches were developed and characterized: DNA-encoded Bispecific T Cell Engagers (DBTEs) and Tri-specific T Cell Engagers …
-
Cytotoxic T cell function in solid tumors: principles and implications for immunotherapy
Activation of the immune system, the body’s own anti-cancer defense, is a promising approach for a range of cancer types with the potential to raise a specific, adaptive and long-lasting anti-cancer protection. In this thesis novel in vitro models which mimic the 3D tissue organization and in vivo …
Page 1 of 8